top of page

Digital Health: Mental Health AI Chatbots

Oct 4, 2024

2 min read

0

75

0

In this article we cover Market size, competitive landscape, regulatory hurdles and risk faced by AI mental health chatbots


I. Market Size of Mental Health Chatbots: ~$24B target spend for AI chatbots expected to grow at ~6% CAGR over the next 5 years




II. Landscape of Mental Health services: Opportunity for AI chatbots to fill in gaps in Telehealth offerings and provide personalized treatment at affordable cost


  • Brick and mortar Facilities (eg. Life Stance):

    • Offered by licensed therapists, psychologists or psychiatrists

    • Therapy is patient or physician initiated

    • $100-250 per session covered by commercial payers

    • Applicable for sub-clinical to clinical diagnoses E.g., stress, depression, schizophrenia, PTSD, ADHD and addiction

  • Telehealth Facilities :

    • Life Coaching (eg. Headspace, Calm) :

      • Offered by unlicensed life coaches

      • Patient initiated

      • $50-100 per year entirely OOP

      • Applicable for sub-clinical conditions eg. stress

    • Teletherapy (eg. Talkspace):

      • Offered by licensed therapist or psychologists

      • Patient initiated

      • $2.5-5K per year ($50-100 per week), largely OOP

      • Applicable for sub-clinical to clinical diagnosis

    • Telepsychiatry (eg. 1 Doc Way)

      • Offered by psychiatrists

      • Physician initiated

      • $5K+ per year ($85-135 per session), covered by commercial payers

      • Applicable for clinical mental health diagnoses



III. Landscape of Mental Health AI Chatbots: Successful companies have developed rules based AI chatbots and received FDA breakthrough status



IV. Regulatory process for Mental Health AI Chatbots:


  • Required for 'medical grade' chatbots only, but can unlock ~100x ticket size per patient ($50-100 per year to $2.5-5K per year)

  • Process:

    • Classified as 'Software as Medical Device' (SaMD)

      • Classified as Class II ('moderate risk') in US and Class II A ('low-medium risk') in EU

    • US FDA / EC came out with initial AI action plans in 2021, final regulation expected in 2024-25 

    • Expect 2-4 years to complete process post FDA approval (see detailed process and levers to accelerate process below




Source: ISPE




V. Mental Health AI Chatbots




Oct 4, 2024

2 min read

0

75

0

Related Posts

Comments

Share Your ThoughtsBe the first to write a comment.
bottom of page